| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.952 | 0.001 | 0.952 | Dopamine transporter inhibitor | 0.909 0.001 CID_154699498 | ||
| 0.932 | 0.001 | 0.932 | Dopamine uptake inhibitor | 0.863 0.002 CID_154699498 | ||
| 0.888 | 0.003 | 0.888 | Psychostimulant | 0.839 0.004 CID_154699498 | ||
| 0.825 | 0.002 | 0.825 | Anesthetic local | 0.709 0.003 CID_154699498 | ||
| 0.791 | 0.003 | 0.832 | 5 Hydroxytryptamine uptake inhibitor | 0.832 0.003 CID_154699498 | CID_154699498 | |
| 0.751 | 0.003 | 0.751 | Anesthetic general | 0.499 0.008 CID_154699498 | ||
| 0.743 | 0.005 | 0.743 | Spasmolytic | 0.517 0.021 CID_154699498 | ||
| 0.674 | 0.003 | 0.674 | Acetylcholine M1 receptor antagonist | 0.526 0.004 CID_154699498 | ||
| 0.672 | 0.003 | 0.672 | Cholinergic antagonist | 0.59 0.004 CID_154699498 | ||
| 0.671 | 0.003 | 0.671 | Acetylcholine antagonist | 0.589 0.004 CID_154699498 | ||
| 0.654 | 0.003 | 0.719 | Adrenaline uptake inhibitor | 0.719 0.002 CID_154699498 | CID_154699498 | |
| 0.579 | 0.003 | 0.579 | Acetylcholine muscarinic antagonist | 0.46 0.004 CID_154699498 | ||
| 0.545 | 0.004 | 0.545 | Acetylcholine nicotinic antagonist | 0.474 0.004 CID_154699498 | ||
| 0.528 | 0.004 | 0.528 | 5 Hydroxytryptamine uptake stimulant | 0.505 0.004 CID_154699498 | ||
| 0.53 | 0.041 | 0.641 | Analgesic | 0.641 0.02 CID_154699498 | CID_154699498 | |
| 0.483 | 0.011 | 0.483 | Sigma receptor agonist | 0.16 0.079 CID_154699498 | ||
| 0.421 | 0.02 | 0.441 | Vasodilator | 0.441 0.017 CID_154699498 | CID_154699498 | |
| 0.438 | 0.057 | 0.497 | Calcium channel L-type activator | 0.497 0.029 CID_154699498 | CID_154699498 | |
| 0.373 | 0.004 | 0.373 | Neuronal nicotinic receptor antagonist | 0.323 0.005 CID_154699498 | ||
| 0.385 | 0.031 | 0.454 | Calcium channel activator | 0.454 0.01 CID_154699498 | CID_154699498 | |
| 0.352 | 0.008 | 0.363 | DNA polymerase I inhibitor | 0.363 0.008 CID_154699498 | CID_154699498 | |
| 0.357 | 0.02 | 0.357 | P-glycoprotein inhibitor | 0.294 0.03 CID_154699498 | ||
| 0.346 | 0.011 | 0.346 | 5 Hydroxytryptamine 1E antagonist | 0.221 0.108 CID_154699498 | ||
| 0.369 | 0.054 | 0.369 | Immunomodulator | 0.318 0.073 CID_154699498 | ||
| 0.301 | 0.004 | 0.301 | Acetylcholine M2 receptor antagonist | 0.188 0.007 CID_154699498 | ||
| 0.295 | 0.003 | 0.304 | Nicotinic alpha4beta2 receptor antagonist | 0.304 0.003 CID_154699498 | CID_154699498 | |
| 0.334 | 0.081 | 0.334 | Vasodilator, peripheral | 0.315 0.09 CID_154699498 | ||
| 0.253 | 0.007 | 0.253 | Opioid kappa receptor antagonist | 0.096 0.039 CID_154699498 | ||
| 0.234 | 0.005 | 0.234 | Acetylcholine M3 receptor antagonist | 0.16 0.01 CID_154699498 | ||
| 0.232 | 0.019 | 0.232 | ATPase inhibitor | 0.19 0.046 CID_154699498 | ||
| 0.299 | 0.088 | 0.299 | Vasodilator, coronary | 0.294 0.093 CID_154699498 | ||
| 0.206 | 0.005 | 0.206 | Nicotinic receptor alpha3 subunit antagonist | 0.164 0.006 CID_154699498 | ||
| 0.204 | 0.005 | 0.204 | Acetylcholine M4 receptor antagonist | 0.197 0.006 CID_154699498 | ||
| 0.25 | 0.066 | 0.295 | DNA synthesis inhibitor | 0.295 0.045 CID_154699498 | CID_154699498 | |
| 0.283 | 0.102 | 0.283 | Cholesterol antagonist | 0.274 0.108 CID_154699498 | ||
| 0.218 | 0.039 | 0.218 | Cytidine deaminase inhibitor | 0.146 0.079 CID_154699498 | ||
| 0.189 | 0.016 | 0.189 | Opioid antagonist | 0.084 0.064 CID_154699498 | ||
| 0.177 | 0.011 | 0.177 | Analgesic, opioid | 0.13 0.019 CID_154699498 | ||
| 0.181 | 0.025 | 0.181 | Expectorant | 0.151 0.035 CID_154699498 | ||
| 0.168 | 0.016 | 0.168 | Prolactin inhibitor | 0.141 0.026 CID_154699498 | ||
| 0.171 | 0.022 | 0.171 | Protein kinase C gamma inhibitor | 0.128 0.046 CID_154699498 | ||
| 0.153 | 0.004 | 0.162 | Nicotinic alpha3beta2 receptor antagonist | 0.162 0.004 CID_154699498 | CID_154699498 | |
| 0.171 | 0.022 | 0.171 | Antineoplastic alkaloid | 0.13 0.034 CID_154699498 | ||
| 0.151 | 0.005 | 0.151 | Opioid kappa receptor agonist | 0.05 0.024 CID_154699498 | ||
| 0.151 | 0.007 | 0.151 | Protein kinase C eta inhibitor | 0.124 0.011 CID_154699498 | ||
| 0.143 | 0.007 | 0.143 | Nicotinic receptor alpha7 subunit antagonist | 0.082 0.016 CID_154699498 | ||
| 0.138 | 0.011 | 0.138 | ATPase (Vacuolar H+) inhibitor | 0.132 0.013 CID_154699498 | ||
| 0.218 | 0.104 | 0.218 | Cardiotonic | |||
| 0.127 | 0.012 | 0.127 | 5 Hydroxytryptamine 3 antagonist | 0.067 0.03 CID_154699498 | ||
| 0.147 | 0.033 | 0.161 | Photosensitizer | 0.161 0.025 CID_154699498 | CID_154699498 | |
| 0.151 | 0.041 | 0.151 | Ca2+-transporting ATPase inhibitor | 0.143 0.062 CID_154699498 | ||
| 0.148 | 0.039 | 0.149 | Microtubule formation inhibitor | 0.149 0.038 CID_154699498 | CID_154699498 | |
| 0.135 | 0.031 | 0.148 | Acetylcholine agonist | 0.148 0.026 CID_154699498 | CID_154699498 | |
| 0.114 | 0.011 | 0.114 | 5 Hydroxytryptamine 3A antagonist | 0.089 0.023 CID_154699498 | ||
| 0.126 | 0.023 | 0.126 | Opioid mu receptor antagonist | |||
| 0.115 | 0.014 | 0.115 | Sigma receptor antagonist | |||
| 0.132 | 0.032 | 0.132 | Acetylcholine release stimulant | |||
| 0.193 | 0.094 | 0.271 | HERG channel blocker | 0.271 0.058 CID_154699498 | CID_154699498 | |
| 0.16 | 0.061 | 0.16 | Protein kinase stimulant | 0.141 0.075 CID_154699498 | ||
| 0.148 | 0.05 | 0.173 | Cyclooxygenase 3 inhibitor | 0.173 0.032 CID_154699498 | CID_154699498 | |
| 0.138 | 0.04 | 0.138 | Mucolytic | 0.122 0.053 CID_154699498 | ||
| 0.103 | 0.012 | 0.103 | Protein kinase C beta inhibitor | 0.086 0.023 CID_154699498 | ||
| 0.097 | 0.007 | 0.097 | 5 Hydroxytryptamine 4 antagonist | 0.053 0.033 CID_154699498 | ||
| 0.128 | 0.04 | 0.128 | Bronchodilator | 0.106 0.057 CID_154699498 | ||
| 0.277 | 0.19 | 0.277 | Apoptosis agonist | |||
| 0.103 | 0.017 | 0.103 | Acetylcholine M5 receptor antagonist | 0.059 0.044 CID_154699498 | ||
| 0.131 | 0.045 | 0.199 | Chelator | 0.199 0.025 CID_154699498 | CID_154699498 | |
| 0.12 | 0.035 | 0.159 | Acetylcholine M3 receptor agonist | 0.159 0.015 CID_154699498 | CID_154699498 | |
| 0.103 | 0.018 | 0.103 | Acetylcholine M5 receptor agonist | |||
| 0.093 | 0.009 | 0.241 | Nicotinic receptor alpha4 subunit antagonist | 0.241 0.003 CID_154699498 | CID_154699498 | |
| 0.098 | 0.018 | 0.098 | Acetylcholine muscarinic agonist | 0.092 0.019 CID_154699498 | ||
| 0.164 | 0.085 | 0.17 | Nitric oxide antagonist | 0.17 0.082 CID_154699498 | CID_154699498 | |
| 0.134 | 0.057 | 0.134 | 5 Hydroxytryptamine antagonist | |||
| 0.182 | 0.11 | 0.255 | Potassium channel (Voltage-sensitive) blocker | 0.255 0.065 CID_154699498 | CID_154699498 | |
| 0.085 | 0.017 | 0.085 | Opioid agonist | 0.059 0.031 CID_154699498 | ||
| 0.132 | 0.067 | 0.185 | Alpha-N-acetylglucosaminidase inhibitor | 0.185 0.039 CID_154699498 | CID_154699498 | |
| 0.07 | 0.008 | 0.07 | Sigma 1 receptor antagonist | |||
| 0.216 | 0.154 | 0.216 | Transcription factor NF kappa B inhibitor | |||
| 0.105 | 0.044 | 0.105 | Calcium antagonist | 0.104 0.045 CID_154699498 | ||
| 0.132 | 0.075 | 0.132 | Calcium channel blocker | 0.13 0.076 CID_154699498 | ||
| 0.089 | 0.033 | 0.089 | Opioid delta receptor antagonist | |||
| 0.07 | 0.014 | 0.07 | 5-Alpha-reductase inhibitor | 0.044 0.022 CID_154699498 | ||
| 0.157 | 0.103 | 0.157 | Hepatoprotectant | 0.154 0.105 CID_154699498 | ||
| 0.071 | 0.019 | 0.071 | Acetylcholine M1 receptor agonist | 0.059 0.022 CID_154699498 | ||
| 0.063 | 0.011 | 0.124 | Nicotinic receptor beta4 subunit antagonist | 0.124 0.005 CID_154699498 | CID_154699498 | |
| 0.159 | 0.113 | 0.159 | Antimitotic | |||
| 0.154 | 0.11 | 0.154 | Non-steroidal antiinflammatory agent | |||
| 0.058 | 0.017 | 0.059 | Microtubule stabilization | 0.059 0.015 CID_154699498 | CID_154699498 | |
| 0.045 | 0.005 | 0.045 | Protein kinase C beta I inhibitor | 0.042 0.007 CID_154699498 | ||
| 0.052 | 0.013 | 0.052 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.166 | 0.127 | 0.192 | Cyclic AMP phosphodiesterase inhibitor | 0.192 0.1 CID_154699498 | CID_154699498 | |
| 0.052 | 0.013 | 0.052 | Farnesoid X receptor agonist | 0.042 0.021 CID_154699498 | ||
| 0.207 | 0.169 | 0.215 | Antithrombotic | 0.215 0.16 CID_154699498 | CID_154699498 | |
| 0.078 | 0.042 | 0.096 | Calcium channel L-type blocker | 0.096 0.027 CID_154699498 | CID_154699498 | |
| 0.146 | 0.111 | 0.146 | Lipocortins synthesis antagonist | |||
| 0.135 | 0.101 | 0.15 | Interferon gamma antagonist | 0.15 0.077 CID_154699498 | CID_154699498 | |
| 0.193 | 0.16 | 0.193 | Gastrin inhibitor | |||
| 0.143 | 0.112 | 0.143 | DNA methyltransferase I inhibitor | |||
| 0.109 | 0.079 | 0.109 | Alkylator | |||
| 0.133 | 0.104 | 0.133 | Heat shock protein 70 antagonist | |||
| 0.272 | 0.243 | 0.272 | Antiinflammatory | |||
| 0.082 | 0.056 | 0.1 | Antineoplastic antibiotic | 0.1 0.046 CID_154699498 | CID_154699498 | |
| 0.081 | 0.055 | 0.094 | Glycine receptor antagonist | 0.094 0.038 CID_154699498 | CID_154699498 | |
| 0.059 | 0.034 | 0.063 | Acetyl-CoA transferase 2 inhibitor | 0.063 0.026 CID_154699498 | CID_154699498 | |
| 0.038 | 0.013 | 0.038 | Protein kinase C beta II inhibitor | 0.038 0.013 CID_154699498 | ||
| 0.072 | 0.05 | 0.072 | Glycine receptor agonist | |||
| 0.096 | 0.077 | 0.096 | Toll-Like receptor 4 antagonist | 0.096 0.078 CID_154699498 | ||
| 0.144 | 0.127 | 0.159 | Angiogenesis stimulant | 0.159 0.117 CID_154699498 | CID_154699498 | |
| 0.027 | 0.01 | 0.027 | 5 Hydroxytryptamine 4 agonist | 0.027 0.011 CID_154699498 | ||
| 0.047 | 0.032 | 0.047 | Opioid mu receptor agonist | |||
| 0.052 | 0.038 | 0.052 | Protein 50S ribosomal subunit inhibitor | |||
| 0.086 | 0.072 | 0.086 | Glutamate release inhibitor | |||
| 0.092 | 0.077 | 0.092 | Nav1.1 sodium channel blocker | |||
| 0.052 | 0.039 | 0.052 | Alpha-mannosidase inhibitor | |||
| 0.104 | 0.093 | 0.104 | Nav1.3 sodium channel blocker | |||
| 0.042 | 0.031 | 0.042 | Dopamine D5 antagonist | |||
| 0.034 | 0.025 | 0.034 | Tubulin agonist | |||
| 0.02 | 0.011 | 0.02 | 5-Alpha-reductase 1 inhibitor | |||
| 0.089 | 0.081 | 0.093 | Anabolic | 0.093 0.073 CID_154699498 | CID_154699498 | |
| 0.055 | 0.048 | 0.056 | Lipocortins synthesis agonist | 0.056 0.045 CID_154699498 | CID_154699498 | |
| 0.02 | 0.013 | 0.02 | 5-Alpha-reductase 2 inhibitor | |||
| 0.076 | 0.07 | 0.076 | GABA A receptor agonist | |||
| 0.046 | 0.041 | 0.046 | HCV NS3/NS4A protease inhibitor | 0.045 0.042 CID_154699498 | ||
| 0.072 | 0.067 | 0.083 | Acetylcholine nicotinic agonist | 0.083 0.053 CID_154699498 | CID_154699498 | |
| 0.028 | 0.024 | 0.031 | Nicotinic alpha3beta4 receptor agonist | 0.031 0.019 CID_154699498 | CID_154699498 | |
| 0.029 | 0.025 | 0.03 | Elastase 3A inhibitor | 0.03 0.021 CID_154699498 | CID_154699498 | |
| 0.029 | 0.025 | 0.03 | Elastase 2B inhibitor | 0.03 0.021 CID_154699498 | CID_154699498 | |
| 0.029 | 0.025 | 0.03 | Elastase 3B inhibitor | 0.03 0.021 CID_154699498 | CID_154699498 | |
| 0.039 | 0.035 | 0.039 | Guanylate cyclase inhibitor | |||
| 0.106 | 0.102 | 0.106 | Nav1.2 sodium channel blocker | |||
| 0.2 | 0.197 | 0.2 | Immunosuppressant | |||
| 0.062 | 0.06 | 0.062 | Glutamate (mGluR7) antagonist | |||
| 0.196 | 0.196 | 0.204 | Interleukin 2 agonist | 0.204 0.182 CID_154699498 | CID_154699498 | |
| 0.088 | 0.093 | 0.102 | Adenylate kinase inhibitor | 0.102 0.063 CID_154699498 | CID_154699498 | |
| 0.192 | 0.199 | 0.196 | Sodium/bile acid cotransporter inhibitor | 0.196 0.193 CID_154699498 | CID_154699498 | |
| 0.025 | 0.033 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.025 CID_154699498 | CID_154699498 | |
| 0.051 | 0.06 | 0.055 | Pregnane X receptor antagonist | 0.055 0.043 CID_154699498 | CID_154699498 | |
| 0.057 | 0.08 | 0.07 | Glutamate (mGluR6) antagonist | 0.07 0.039 CID_154699498 | CID_154699498 | |
| 0.112 | 0.137 | 0.128 | Arachidonic acid antagonist | 0.128 0.116 CID_154699498 | CID_154699498 | |
| 0.036 | 0.063 | 0.046 | Aldosterone antagonist | 0.046 0.035 CID_154699498 | CID_154699498 | |
| 0.156 | 0.184 | 0.166 | RNA-directed DNA polymerase inhibitor | 0.166 0.161 CID_154699498 | CID_154699498 | |
| 0.024 | 0.063 | 0.03 | Glutamate (mGluR3) agonist | 0.03 0.029 CID_154699498 | CID_154699498 | |
| 0.098 | 0.142 | 0.146 | Cholinergic | 0.146 0.08 CID_154699498 | CID_154699498 | |
| 0.065 | 0.118 | 0.095 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.095 0.059 CID_154699498 | CID_154699498 | |
| 0.124 | 0.19 | 0.163 | Interleukin agonist | 0.163 0.155 CID_154699498 | CID_154699498 | |
| 0.077 | 0.148 | 0.097 | TRPA1 agonist | 0.097 0.094 CID_154699498 | CID_154699498 | |
| 0.009 | 0.105 | 0.114 | Dipeptidyl peptidase I inhibitor | 0.114 0.004 CID_154699498 | CID_154699498 | |
| 0.09 | 0.219 | 0.143 | Potassium channel blocker | 0.143 0.142 CID_154699498 | CID_154699498 | |
| 0.047 | 0.197 | 0.089 | GABA C receptor agonist | 0.089 0.08 CID_154699498 | CID_154699498 | |
| 0.136 | 0.323 | 0.22 | Antibacterial | 0.22 0.207 CID_154699498 | CID_154699498 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |